Latest filing published 03 Dec 2025 for Sonnet BioTherapeutics Holdings, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Raghu Rao: trading record in brief
Raghu Rao is a declared insider of Sonnet BioTherapeutics Holdings, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 1 April 2020 to 2 December 2025, the count stands at 8 filings.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants.
On 3 December 2025 came the latest disclosure, a transaction in Sonnet BioTherapeutics Holdings, Inc. The last insider purchase was made public on 27 October 2023, 1,109 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Raghu Rao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,356 sharesCommon StockSEC:0001493152-25-026067:0
- 20,000 sharesCommon StockSEC:0001641172-25-019784:0
- 373 sharesCommon StockSEC:0001493152-24-048955:0
- 15,625 sharesCommon StockSEC:0001493152-23-038574:0Canonical exit: 25 Jan 2024 (T+90)
- 3,770 sharesCommon StockSEC:0001493152-22-036316:0
- 14,152 sharesCommon StockSEC:0001493152-22-009483:0
6 of 6 declarations